{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:46:52Z","timestamp":1791215212739,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,10]]},"DOI":"10.1097\/qad.0b013e328355e6b2","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T13:54:41Z","timestamp":1337349281000},"page":"1765-1774","source":"Crossref","is-referenced-by-count":241,"title":["Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load"],"prefix":"10.1097","volume":"26","author":[{"given":"Michael J.","family":"Peluso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Boschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Gissl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Angoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cinque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Spudich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-199908010-00003","article-title":"Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.","volume":"21","author":"Gisslen","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2334-5-98","article-title":"Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.","volume":"5","author":"Spudich","year":"2005","journal-title":"BMC Infect Dis"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410420503","article-title":"Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.","volume":"42","author":"Ellis","year":"1997","journal-title":"Ann Neurol"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders.","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.10827","article-title":"Changing incidence of central nervous system diseases in the Euro SIDA cohort.","volume":"55","author":"dArminio Monforte","year":"2004","journal-title":"Ann Neurol"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/657342","article-title":"HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.","volume":"202","author":"Eden","year":"2010","journal-title":"J Infect Dis"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.","volume":"24","author":"Simioni","year":"2010","journal-title":"AIDS"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","article-title":"Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.","volume":"50","author":"Canestri","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/aid.2011.0020","article-title":"HIV type 1 viral encephalitis after development of viral resistance to plasma suppressive antiretroviral therapy.","volume":"28","author":"Del Palacio Tamarit","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jinf.2011.05.011","article-title":"Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.","volume":"63","author":"Bogoch","year":"2011","journal-title":"J Infect"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/649874","article-title":"Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid.","volume":"50","author":"van Lelyveld","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1258\/ijsa.2011.010507","article-title":"HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.","volume":"22","author":"Bingham","year":"2011","journal-title":"Int J STD AIDS"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/QAD.0b013e32833dec20","article-title":"Efficacy of darunavirritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.","volume":"24","author":"Katlama","year":"2010","journal-title":"AIDS"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.","volume":"304","author":"Thompson","year":"2010","journal-title":"JAMA"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcv.2008.03.017","article-title":"The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons.","volume":"42","author":"Corcoran","year":"2008","journal-title":"J Clin Virol"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/clinchem\/33.1.62","article-title":"Determination of neopterin in serum and urine.","volume":"33","author":"Werner","year":"1987","journal-title":"Clin Chem"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","article-title":"Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.","volume":"7","author":"Hagberg","year":"2010","journal-title":"AIDS Res Ther"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/00002030-200205030-00008","article-title":"Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy.","volume":"16","author":"Langford","year":"2002","journal-title":"AIDS"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"10830","DOI":"10.1128\/JVI.79.16.10830-10834.2005","article-title":"Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia.","volume":"79","author":"Ritola","year":"2005","journal-title":"J Virol"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1097\/00002030-200009080-00010","article-title":"Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.","volume":"14","author":"Cunningham","year":"2000","journal-title":"AIDS"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00002030-200104130-00010","article-title":"HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with abacavir.","volume":"15","author":"Lanier","year":"2001","journal-title":"AIDS"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/JCM.33.2.352-355.1995","article-title":"Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.","volume":"33","author":"Di Stefano","year":"1995","journal-title":"J Clin Microbiol"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1212\/WNL.56.3.355","article-title":"Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy.","volume":"56","author":"Stingele","year":"2001","journal-title":"Neurology"},{"key":"R28-5-20210130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","article-title":"Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.","volume":"25","author":"Smurzynski","year":"2011","journal-title":"AIDS"},{"key":"R29-5-20210130","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/508750","article-title":"Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.","volume":"194","author":"Spudich","year":"2006","journal-title":"J Infect Dis"},{"key":"R30-5-20210130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation.","volume":"3","author":"Murr","year":"2002","journal-title":"Curr Drug Metab"},{"key":"R31-5-20210130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molimm.2004.06.017","article-title":"Neopterin in HIV-1 infection.","volume":"42","author":"Wirleitner","year":"2005","journal-title":"Mol Immunol"},{"key":"R32-5-20210130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00401-004-0852-0","article-title":"Cerebral CD8 lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART.","volume":"108","author":"Miller","year":"2004","journal-title":"Acta Neuropathol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201209100-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:16:57Z","timestamp":1618039017000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201209100-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,10]]},"references-count":29,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328355e6b2","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,10]]}}}